clock menu more-arrow no yes mobile

Filed under:

Dallas Stars Friday Links: Methot Might Miss Tonight’s Matchup

Too bad it isn’t a Monday to complete the alliteration. Plus practice notes, Vadim Shipachyov retires from the NHL, and players to keep an eye on as the season progresses.

NHL: Dallas Stars at Vancouver Canucks Anne-Marie Sorvin-USA TODAY Sports

In case you thought the Dallas Stars didn’t have enough injured players already, Marc Methot missed his second consecutive practice yesterday, which does not bode well for tonight’s game against the New York Islanders:

"Methot didn't skate again today, so he is probably going to miss the game on Friday," said Stars coach Ken Hitchcock. "That's not 100 percent yet, but there's a chance he could miss."

Hitchcock said Methot is listed as day-to-day and did not expect the injury to be long-term.

Methot joins forwards Brett Ritchie, Tyler Pitlick, and Radek Faksa on the injury report. If none of the four are able to play, then the Stars will have to callup a player from Cedar Park:

"I think a call-up is a possibility because you don't want to put yourself in a position where you are bringing guys out of rehab with one skate," said Hitchcock. "We'll talk about it, but I don't think any of those guys are 100 percent ready yet. With one more skate, they might be. We'll evaluate that a little bit later, but I think there is the possibility of a call-up."

You can read more about yesterday’s practice in Mark Stepneski’s piece here.

Here’s more on the injuries from Ken Hitchcock, plus Gemel Smith on playing with Jamie Benn and Alexander Radulov:

Sean Shapiro has a short and sweet story on a Texas Stars fan named Kade O’Rourke (who’s also a pretty good hockey player for a 6 year old) that’s worth a click. [Wrong Side of the Red Line]

Speaking of the Texas Stars, here’s some great news thanks to Texas voters:

Ken Hitchcock takes a trip down memory lane as he congratulates former mentor Clare Drake for his upcoming induction into the Hockey Hall of Fame. [NHL]

I think I’m in love, guys:

In fact, let’s all watch it again, only closer and in slow motion:


Around the League

Well that didn’t last long: Vadim Shipachyov has retired from the NHL and will be returning to Russia. [Las Vegas Sun]

Apparently the Vegas Golden Knights found a trade partner, but respected Shipachyov’s wishes.

Speaking of trades, Sam Bennett’s become a popular name in trade rumors, and the Calgary Flames should probably start listening to offers. [Sportsnet]

It’s still early in the season, but some issues have cropped up (such as the Stars’ even strength scoring woes) that need fixing asap. [FanRag Sports]

On a similar note, here’s a look at the Minnesota Wild’s rough start to the season:

Of course by writing that article, Ken Campbell practically guaranteed the Wild’s 3-0 shutout victory over the Montreal Canadiens last night. [Hockey Wilderness]

The St. Louis Blues meanwhile edged the Arizona Coyotes 3-2 in the shootout. [St. Louis Gametime]

The Chicago Blackhawks weren’t nearly as fortunate as their Central rivals, dropping a 3-1 decision to the Philadelphia Flyers. [Second City Hockey]

I’m not exactly a fan of the Anaheim Ducks, but I’m a sucker for this sort of stuff:

It’s never too early to look towards the summer: John Tavares, who we’ll see firsthand tonight, headlines Matt Larkins’ 30 upcoming UFAs. [The Hockey News]

If you think the NHL hasn’t been at least a little weird this season, consider the fact that eleven different defensemen have taken faceoffs so far. [Yahoo Sports]

I, for one, do not miss any of these logos (though the Rangers’ would make for a pretty solid throwback jersey, imo):

If you thought Benn-Seguin-Radulov was an unstoppable line (R.I.P.), then you haven’t seen Namestnikov-Stamkos-Kucherov play. [TSN]

Speaking of which, Vladislav Namestnikov headlines five underrated players you should keep an eye on this season. [FanRag Sports]


Finally...

Here’s your feel-good story for the day: Brian Boyle scored his first goal last night after being diagnosed with cancer.